Insider Transactions in Q1 2025 at Precision Biosciences Inc (DTIL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2025
|
Melinda Brown |
BUY
Open market or private purchase
|
Direct |
1,839
+16.88%
|
$7,356
$4.75 P/Share
|
|
Mar 26
2025
|
Kevin Buehler |
BUY
Open market or private purchase
|
Direct |
4,523
+25.47%
|
$18,092
$4.67 P/Share
|
|
Mar 25
2025
|
Geno J Germano |
BUY
Open market or private purchase
|
Direct |
3,250
+22.72%
|
$16,250
$5.3 P/Share
|
|
Mar 24
2025
|
Michael Amoroso President and CEO |
SELL
Open market or private sale
|
Direct |
964
-0.87%
|
$4,820
$5.56 P/Share
|
|
Mar 21
2025
|
Michael Amoroso President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,417
+3.0%
|
-
|
|
Mar 04
2025
|
Dario Scimeca General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
272
-1.08%
|
$1,088
$4.91 P/Share
|
|
Mar 04
2025
|
J. Jefferson Smith Chief Research Officer |
SELL
Open market or private sale
|
Direct |
154
-0.18%
|
$616
$4.91 P/Share
|
|
Mar 03
2025
|
Dario Scimeca General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
919
+3.51%
|
-
|
|
Mar 03
2025
|
John Alexander Kelly Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,702
+1.94%
|
-
|
|
Mar 03
2025
|
J. Jefferson Smith Chief Research Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
519
+0.59%
|
-
|
|
Jan 22
2025
|
J. Jefferson Smith Chief Research Officer |
SELL
Open market or private sale
|
Direct |
10,287
-10.53%
|
$41,148
$4.79 P/Share
|
|
Jan 22
2025
|
Dario Scimeca General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
8,928
-26.83%
|
$35,712
$4.79 P/Share
|
|
Jan 21
2025
|
Michael Amoroso President and CEO |
SELL
Open market or private sale
|
Direct |
36,838
-25.6%
|
$147,352
$4.67 P/Share
|
|
Jan 20
2025
|
J. Jefferson Smith Chief Research Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,168
+22.99%
|
-
|
|
Jan 20
2025
|
Michael Amoroso President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
115,388
+44.5%
|
-
|
|
Jan 20
2025
|
John Alexander Kelly Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,368
+34.41%
|
-
|
|
Jan 20
2025
|
Dario Scimeca General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
25,312
+43.2%
|
-
|